We subsequently used Kaplan‐Meier plotter to perform Kaplan‐Meier analysis of the publicly available data to determine whether CD47 expression affects the outcomes of patients with ccRCC. This evidence concerns the gene CD47 and nonpapillary renal cell carcinoma.